Dr. Navarro-Millan is a rheumatologist with expertise in rheumatoid arthritis. She has more than 5 years of experience in the field. Her background gives her expertise working with different populations and to provide sensitive and compassionate care for her patients. This care is focused on empowering patients to participate in their treatment decision making and overall care.
She is a member of the American College of Rheumatology (ACR) and has served as an ad hoc journal reviewer for: Arthritis & Rheumatism, Journal of Rheumatology, Arthritis Care and Research, Seminars in Arthritis and Rheumatism and Arthritis Research & Therapy.
She is a clinical researcher and her research is directed towards rheumatoid arthritis. She is funded by the NIH to conduct clinical and patient–centered research focus in cardiovascular risk reduction among patients with rheumatoid arthritis.
Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor, Weill Cornell Medical College
Assistant Professor, NewYork-Presbyterian Hospital
Intra-articular joint injections
Tendon sheath injections
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may still have coverage subject to the availability of 'out-of-network' benefits.
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of July 18, 2017, Dr. Navarro-Millan reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Board Certified in Internal Medicine 2009-2019
Board Certified in Rheumatology 2011-2021
Navarro-Millán IY, Alarcón G S: "Lippincott's Primary Care Rheumatology." Book Chapter: "Overlap Syndromes and Unclassified or Undifferentiated Connective Tissue Disease" Lippincott, Williams & Wilkins. 2011: ISBN/ISSN: 9781609138080.
Navarro-Millán I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW, Delzell ES, Zhang J, Safford M, Patkar NM, Mikuls TR, Singh JA, Curtis JR. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis. Feb 2016;75(2):341-347. PMCID: PMC4752663
Navarro-Millán I, Charles-Schoeman C, Yang S, Bathon J, Bridges L, Chen L, Cofield S, Dell'talia LJ, Moreland L, O'Dell JR, Paulus HE, Curtis JR. 2013. Changes in Lipoproteins Associated with MTX, MTX + Etanercept, and Triple DMARD Therapy among Early RA Patients in the TEAR Trial. Arthritis Rheum. 65(6):1430-8. PMCID: PMC3672346.
Charles-Schoeman C, Wang X, Lee YY, Shahbazian A, Navarro-Millán I, Yang S, Chen L, Cofield SS, Moreland LW, O'Dell J, Bathon J, Paulus H, Bridges SL Jr, Curtis JR. Association of Triple Therapy with Improvement in Cholesterol Profiles over Two Year Follow-up in the TEAR Trial. Arthritis Rheumatol. 2016 Mar;68(3):577-86. PMCID: PMC4774543.
Navarro-Millán I, Herrinton L, Chen L, Liyan L, Curtis JR. Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability. PloS one. 2016;11(3):e0149781. PMCID: PMC4805235
Navarro-Millán I, Chen L, Greenberg J, Pappas DA, Curtis JR. 2013. Predictors and Persistence of new-onset clinical remission in rheumatoid arthritis patients. Semin Arthritis Rheum 43(2):137-143. PMCID: PMC4184191.
Navarro-Millán I, Singh JA, Curtis JR. 2012. Systematic review of tocilizumab for Rheumatoid Arthritis: A New Biologic Targeting the Interleukin-6 Receptor. Clin Ther 34(4):788-802.e3. PMCID: PMC3805022
Navarro-Millán I, Sattui SE, Curtis JR. 2013. Systematic Review of Tumor Necrosis Factor Inhibitor Discontinuation Studies in Rheumatoid Arthritis. Clin Ther 35(11):1850-1861 e1. PMCID: PMC3917677
Navarro-Millán I, Curtis JR. 2013. Newest clinical trial results with antitumor necrosis factor and non-anti-tumor necrosis factor biologics for rheumatoid arthritis. Curr Opin Rheumatol 25(3):384-90. PMCID: PMC4041208
Navaro-Millán I, Darrah E, Westfall AO, Mikuls TE, Reynolds RJ, Danila MI, Curtis JR, Bridges SL. Association of Anti-Peptidyl Arginine Deiminase Antibodies with Radiographic Severity of Rheumatoid Arthritis in African Americans. Arthritis Res Ther. 2016 Oct 22;18(1):241. PMCID: PMC5075170
Costenbader KH, Khamashta M, Ruiz-Garcia S, Perez-Rodriguez MT, Petri M, Elliott J, Manzi S, Karlson EW, Turner-Stokes T, Bermas B, Coblyn J, Massarotti E, Schur P, Fraser P, Navarro I, Hanly JG, Shaver TS, Katz RS, Chakravarty E, Fortin PR, Sanchez ML, Liu J, Michaud K, Alarcón GS, Wolfe F. 2010. Development and initial validation of a self-assessed lupus organ damage instrument. Arthritis Care Res. 62(4):559-68. PMCID: PMC 3179258.
For more publications, please the PubMed listing.
5/2012 6th National Young Research Investigator Forum, "American College of Rheumatology Annual Scientific Meeting, "Application of the New American College of Rheumatology/European League Against Rheumatism Rheumatoid Arthritis Remission Criteria in a United States Cohort" (Abstract Oral presentation) Destin, FL
9/2014 Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center (CAMAC) Research Day. "Association of Anti-Peptidyl Arginine Deiminase Antibodies with Radiographic Severity of Rheumatoid Arthritis in African Americans" (Abstract Oral Presentation) Birmingham, AL
4/2016 "Using Rheumatoid Arthritis Clinical Outcomes to Develop Patient Centered Research Questions" National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) – Grand Rounds. Bethesda, Maryland
7/2016 "PROs in Rheumatoid Arthritis: Electronic Data Capture to Improve Patient Outcomes" Investigators Meeting –Rheumatology Research Foundation. Atlanta, GA